VITALITI Tricorder wins Epic Innovator Prize at XPRIZE Awards
When AgeWell Toronto invited Cortex President Dylan Horvath to present a workshop to their network of researchers and entrepreneurs, our goal was to relate the vital importance of using ethnography to de-risk the product design process. Many startups (especially those under time pressure and budget limitations) choose to dive straight into development, assuming the product…
As the healthcare sector emerges from the pandemic, providers and their medtech manufacturers face a much-changed economic, commercial, and competitive landscape. But one thing remains true – the decision to invest in cutting-edge tools isn’t merely a choice; it’s the cornerstone of successful medtech manufacturing. In this article, we delve into the transformative power of…
A primer from Cortex Design. All medical devices marketed in the U.S. are regulated by the Food and Drug Administration (FDA). The FDA classifies any new medical device as either Class I, Class II, or Class III, depending on the device’s risk, invasiveness, and a number of other factors. If you want to market a…
Design reviews are a mandatory part of medical device development and are often mistakenly treated as a compliance checkbox. When done properly, however, they can become a meaningful competitive advantage. This article explains why medical device design reviews matter and how to conduct them effectively—from what a design review is and who should be involved,…
The Qualcomm Tricorder XPRIZE is a $10 million global competition to stimulate innovation and integration of precision diagnostic technologies, helping consumers make their own reliable health diagnoses anywhere, anytime. Later this year the Qualcomm Tricorder XPRIZE will announce its winners. The VITALITI Health Monitoring System has been named a top-7 finalist in the prestigious $10M…
Two recent McKinsey reports offer insights and predictions for medtech success, based on conversations with industry leaders and McKinsey’s research. “What to expect from medtech in 2024” discusses the uneven performance of the medtech industry in 2023, highlighting factors such as revenue growth, product approvals, and investor sentiment. Seven key predictions are made for 2024,…